9781937258177-1937258173-Current Good Manufacturing Practices: Pharmaceutical, Biologics, and Medical Device Regulations and Guidance Documents, Concise Reference, Second Edition

Current Good Manufacturing Practices: Pharmaceutical, Biologics, and Medical Device Regulations and Guidance Documents, Concise Reference, Second Edition

ISBN-13: 9781937258177
ISBN-10: 1937258173
Edition: 2
Author: Mindy J. Allport-Settle, Dr. Kirstin A. Counts
Publication date: 2018
Publisher: PharmaLogika Books
Format: Paperback 686 pages
FREE US shipping
Buy

From $45.18

Book details

ISBN-13: 9781937258177
ISBN-10: 1937258173
Edition: 2
Author: Mindy J. Allport-Settle, Dr. Kirstin A. Counts
Publication date: 2018
Publisher: PharmaLogika Books
Format: Paperback 686 pages

Summary

Current Good Manufacturing Practices: Pharmaceutical, Biologics, and Medical Device Regulations and Guidance Documents, Concise Reference, Second Edition (ISBN-13: 9781937258177 and ISBN-10: 1937258173), written by authors Mindy J. Allport-Settle, Dr. Kirstin A. Counts, was published by PharmaLogika Books in 2018. With an overall rating of 4.0 stars, it's a notable title among other books. You can easily purchase or rent Current Good Manufacturing Practices: Pharmaceutical, Biologics, and Medical Device Regulations and Guidance Documents, Concise Reference, Second Edition (Paperback) from BooksRun, along with many other new and used books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $1.74.

Description

FDA Regulations and Associated Guidance Documents: - Code of Federal Regulation Title 21 Overview - Part 11 Electronic Records; Electronic Signatures (21CFR§11) and Guidance for Industry - Part 26 Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports: United States and The European Community (21CFR§26) - Part 200 Drugs: General (21CFR§200) - Part 207 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs, and The National Drug Code (21CFR§207) - Part 210 Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General (21CFR§210) - Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals (21CFR§211) - Part 600 Biological Products: General (21CFR§600) - Part 807 Establishment Registration and Device Listing for Manufacturers and Initial Importers of Devices (21CFR§807) - Part 820 Quality System Regulation (21CFR§820) - Part 11, Electronic Records; Electronic Signatures — Scope and Application - Guidance for Industry and FD A Staff: Current Good Manufacturing Practice Requirements for Combination Products - Guidance for Industry: CGMP for Phase 1 Investigational Drugs - Process Validation: General Principles and Practices - PAT — A Frame work for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance - Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations - Contract Manufacturing Arrangements for Drugs: Quality Agreements - Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP - Formal Dispute Resolution: Sponsor Appeals Above the Division Level Reference Tools: - Glossaries combined in one location - GMP Keyword Index for 21CFR211 - Combined Index for all documents

Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book